Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 2
Submit an article Journal homepage
735
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis

Axel U. DignassDepartment of Medicine I, Agaplesion Markus Hospital, Goethe-University, Frankfurt am Main, Germany; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9724-054XView further author information
ORCID Icon,
Britta SiegmundDepartment of Medicine(Gastroenterology, Infectious Diseases, Rheumatology), Charité–Universitätsmedizin Berlin, Berlin, Germany; View further author information
,
Ralf GoertzAMS Advanced Medical Services GmbH, Mannheim, Germany; ORCID Iconhttp://orcid.org/0000-0001-7564-8635View further author information
ORCID Icon,
Gundula SchneidewindTakeda Pharmaceuticals International AG, Zurich, Switzerland; View further author information
&
Lena FanterTakeda Pharma Vertrieb GmbH & Co. KG, Berlin, GermanyORCID Iconhttp://orcid.org/0000-0002-9631-739XView further author information
ORCID Icon
Pages 178-187 | Received 13 Oct 2018, Accepted 07 Jan 2019, Published online: 08 Feb 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vipul Jairath, Keith Chan, Karen Lasch, Sam Keeping, Christian Agboton, Aimee Blake & Haridarshan Patel. (2021) Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 15:6, pages 711-722.
Read now

Articles from other publishers (2)

Tommaso Innocenti, Jenny Roselli, Erica N. Lynch, Pasquale Apolito, Laura Parisio, Siro Bagnoli, Giuseppe Macrì, Francesca Rogai, Mirko Tarocchi, Stefano Milani, Andrea Galli, Monica Milla & Gabriele Dragoni. (2021) Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 33:1S, pages e574-e579.
Crossref
Sebastian Zundler, Maximilian Wiendl & Markus F. Neurath. (2019) Anti-trafficking agents in the treatment of inflammatory bowel disease. Current Opinion in Gastroenterology 35:6, pages 499-506.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.